Company announces roadmap anchored by new two plate workflow enabling preparation of samples up to 2 million cells and beyond. New collaborations with Vizgen, BioLegend, and SPT Labtech will extend range.

New system enables advanced analysis of live cell cultures with high-definition, high-speed 3D imaging. Expands Yokogawa’s CellVoyager range to support research applications from basic science to drug discovery screening.

AMSBIO has launched a new 2024 travel grant award scheme for scientists under the age of thirty, employed in academia, research institutions, or companies engaged in cancer and stem cell research.

Thermo Fisher Scientific launches next-generation Invitrogen TaqMan Cells-to-CT Express Kit with simplified, more sustainable workflow.

The project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN trial. The Assay will be available as a service in the Babraham Institute’s Flow Cytometry Facility.

A new energised Argenta brand campaign – One Brand, One Vision – emphasises the company's commitment to advancing world-class treatments and therapies for healthier and happier animals by delivering trusted, innovative ‘molecule to market’ solutions to customers.

CELLBANKER® freezing media from AMSBIO is now available in customizable formats, seamlessly integrating into cell manufacturing processes with personalized formulations, volumes, and packaging.

License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness.

HP Inc., recently announced that it has entered into a new, commercial agreement with valued strategic partner Tecan, to make the Uno Single Cell Dispenser available to life science and pharma researchers worldwide.

Innovation provides United States with first workflow update in 25 years.